167 related articles for article (PubMed ID: 38247210)
1. A Replication-Competent Retroviral Vector Expressing the HERV-W Envelope Glycoprotein is a Potential Tool for Cancer Gene Therapy.
Kang BK; Jung YT
J Microbiol Biotechnol; 2024 Feb; 34(2):280-288. PubMed ID: 38247210
[TBL] [Abstract][Full Text] [Related]
2. Construction of replication-competent oncolytic retroviral vectors expressing R peptide-truncated 10A1 envelope glycoprotein.
Lee ES; Jin SY; Kang BK; Jung YT
J Virol Methods; 2019 Jun; 268():32-36. PubMed ID: 30898575
[TBL] [Abstract][Full Text] [Related]
3. Construction of a replication-competent retroviral vector for expression of the VSV-G envelope glycoprotein for cancer gene therapy.
Jin SY; Jung YT
Arch Virol; 2020 May; 165(5):1089-1097. PubMed ID: 32146506
[TBL] [Abstract][Full Text] [Related]
4. Production of a replicating retroviral vector expressing Reovirus fast protein for cancer gene therapy.
Jeon YH; Jung YT
J Virol Methods; 2022 Jan; 299():114332. PubMed ID: 34655690
[TBL] [Abstract][Full Text] [Related]
5. The envelope glycoprotein of human endogenous retrovirus HERV-W induces cellular resistance to spleen necrosis virus.
Ponferrada VG; Mauck BS; Wooley DP
Arch Virol; 2003 Apr; 148(4):659-75. PubMed ID: 12664292
[TBL] [Abstract][Full Text] [Related]
6. Construction of SARS-CoV-2 spike-pseudotyped retroviral vector inducing syncytia formation.
Lee SY; Kim DW; Jung YT
Virus Genes; 2022 Jun; 58(3):172-179. PubMed ID: 35322356
[TBL] [Abstract][Full Text] [Related]
7. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
Qiao J; Moreno J; Sanchez-Perez L; Kottke T; Thompson J; Caruso M; Diaz RM; Vile R
Gene Ther; 2006 Oct; 13(20):1457-70. PubMed ID: 16724095
[TBL] [Abstract][Full Text] [Related]
8. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor.
Blond JL; Lavillette D; Cheynet V; Bouton O; Oriol G; Chapel-Fernandes S; Mandrand B; Mallet F; Cosset FL
J Virol; 2000 Apr; 74(7):3321-9. PubMed ID: 10708449
[TBL] [Abstract][Full Text] [Related]
9. Envelope gene of the human endogenous retrovirus HERV-W encodes a functional retrovirus envelope.
An DS; Xie Ym ; Chen IS
J Virol; 2001 Apr; 75(7):3488-9. PubMed ID: 11238877
[TBL] [Abstract][Full Text] [Related]
10. The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors.
Lavillette D; Marin M; Ruggieri A; Mallet F; Cosset FL; Kabat D
J Virol; 2002 Jul; 76(13):6442-52. PubMed ID: 12050356
[TBL] [Abstract][Full Text] [Related]
11. Chromosomal distribution and coding capacity of the human endogenous retrovirus HERV-W family.
Voisset C; Bouton O; Bedin F; Duret L; Mandrand B; Mallet F; Paranhos-Baccala G
AIDS Res Hum Retroviruses; 2000 May; 16(8):731-40. PubMed ID: 10826480
[TBL] [Abstract][Full Text] [Related]
12. Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancer.
Lin EH; Salon C; Brambilla E; Lavillette D; Szecsi J; Cosset FL; Coll JL
Cancer Gene Ther; 2010 Apr; 17(4):256-65. PubMed ID: 19893593
[TBL] [Abstract][Full Text] [Related]
13. An N-terminally truncated envelope protein encoded by a human endogenous retrovirus W locus on chromosome Xq22.3.
Roebke C; Wahl S; Laufer G; Stadelmann C; Sauter M; Mueller-Lantzsch N; Mayer J; Ruprecht K
Retrovirology; 2010 Aug; 7():69. PubMed ID: 20735848
[TBL] [Abstract][Full Text] [Related]
14. Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
Farson D; McGuinness R; Dull T; Limoli K; Lazar R; Jalali S; Reddy S; Pennathur-Das R; Broad D; Finer M
J Gene Med; 1999; 1(3):195-209. PubMed ID: 10738568
[TBL] [Abstract][Full Text] [Related]
15. Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line.
Garrett E; Miller AR; Goldman JM; Apperley JF; Melo JV
Virology; 2000 Jan; 266(1):170-9. PubMed ID: 10612671
[TBL] [Abstract][Full Text] [Related]
16. Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.
Robinson LR; Whelan SP
J Virol; 2016 Jan; 90(7):3640-9. PubMed ID: 26792739
[TBL] [Abstract][Full Text] [Related]
17. Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.
Blaise S; de Parseval N; Bénit L; Heidmann T
Proc Natl Acad Sci U S A; 2003 Oct; 100(22):13013-8. PubMed ID: 14557543
[TBL] [Abstract][Full Text] [Related]
18. Expression of the human endogenous retrovirus HERV-W family in various human tissues and cancer cells.
Yi JM; Kim HM; Kim HS
J Gen Virol; 2004 May; 85(Pt 5):1203-1210. PubMed ID: 15105536
[TBL] [Abstract][Full Text] [Related]
19. Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation.
Frendo JL; Olivier D; Cheynet V; Blond JL; Bouton O; Vidaud M; Rabreau M; Evain-Brion D; Mallet F
Mol Cell Biol; 2003 May; 23(10):3566-74. PubMed ID: 12724415
[TBL] [Abstract][Full Text] [Related]
20. Human endogenous retrovirus W family envelope gene activates the small conductance Ca2+-activated K+ channel in human neuroblastoma cells through CREB.
Li S; Liu ZC; Yin SJ; Chen YT; Yu HL; Zeng J; Zhang Q; Zhu F
Neuroscience; 2013 Sep; 247():164-74. PubMed ID: 23727510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
